1383. Everolimus is Associated with an Increased Risk of Tuberculosis in Solid-Organ Transplant Recipients

BACKGROUND: Tuberculosis (TB) is an important post-transplant infection. Everolimus has been documented to reduce the risk of cytomegalovirus infection in transplant recipients, but its impact on other infections is less known. The present study aimed to assess immunosuppressive regimens on TB risk...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Open Forum Infect Dis
Glavni autori: Sun, Hsin-Yun, Cheng, Aristine, Wang, So-Meng, Tsai, Meng-Kun, Chen, Yih-Sharng, Wang, Sheoi-Shen, Ho, Cheng-Maw, Hu, Rey-Heng, Hsu, Hsao-Hsun, Fang, Chi-Tai, Chen, Yee-Chun, Chang, Shan-Chwen
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6808879/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1247
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items